19起交易超46亿美元!信诺维15.4亿美元ADC授权领跑、礼来达成10亿美元并购 | 一周交易

创鉴汇
Jun 05

据创鉴汇不完全统计,5月26日至6月1日全球生物制药领域共披露19起交易事件,潜在交易总额超46亿美元,其中超亿美元的大额交易达6起。交易类型涵盖合作研发8起、药物授权7起、并购和技术授权各2起。上周交易呈现以下特点:药物类型分布较集中,小分子和抗体药物仍是交易主力,合计占比近50%。此外,RNAi药物逐渐成为焦点。上周潜在交易总额排行前三的交易事件均涉及以上3类药物:信诺维的抗体偶联药物以...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10